Tao Zhang

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 584 citations

Medicine, Oncology, Pharmacology +14

Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · The Lancet Respiratory Medicine · 2020 · 505 citations

Medicine, Oncology, Pharmacology +13

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan et al. · Nature Communications · 2022 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease

Zhiyong Guo, Qiang Zhao, Zehua Jia et al. · Journal of Hepatology · 2023 · 119 citations · Full text

Medicine, Surgery, Transplant Surgery +9

Seasonal variation of manic and depressive symptoms in bipolar disorder

Ahmed Akhter, Jess G. Fiedorowicz, Tao Zhang et al. · Bipolar Disorders · 2013 · 45 citations

Medicine, Psychiatry, Psychology +17